aluates Reports

$ 0.0

Automative

Global Antisense Oligonucleotides (ASO) Therapy Market Research Report 2026

Published Date: 2026-03-25

Report Code: QYRE-Auto-11J17453

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

BUY CHAPTERS

Global Antisense Oligonucleotides (ASO) Therapy Market Research Report 2026

Code: QYRE-Auto-11J17453

Report

2026-03-25

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ionis Pharmaceuticals

Biogen

SOBI

Nippon Shinyaku

Jazz Pharmaceuticals

Antisense Oligonucleotides (ASO) Therapy Market Size

The global Antisense Oligonucleotides (ASO) Therapy market was valued at US$ 4654 million in 2025 and is anticipated to reach US$ 14040 million by 2032, at a CAGR of 17.3% from 2026 to 2032.

Antisense Oligonucleotides (ASO) Therapy Market

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases

The North American market for Antisense Oligonucleotides (ASO) Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Antisense Oligonucleotides (ASO) Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Antisense Oligonucleotides (ASO) Therapy in Neuromuscular Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Antisense Oligonucleotides (ASO) Therapy include Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Antisense Oligonucleotides (ASO) Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antisense Oligonucleotides (ASO) Therapy. The Antisense Oligonucleotides (ASO) Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Antisense Oligonucleotides (ASO) Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Antisense Oligonucleotides (ASO) Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Antisense Oligonucleotides (ASO) Therapy Market Report

Report Metric	Details
Report Name	Antisense Oligonucleotides (ASO) Therapy Market
Accounted market size in 2025	US$ 4654 million
Forecasted market size in 2032	US$ 14040 million
CAGR	17.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Intrathecal Injection Intravenous Injections Other
Segment by Application	Neuromuscular Diseases hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Antisense Oligonucleotides (ASO) Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Antisense Oligonucleotides (ASO) Therapy Market growing?

Ans: The Antisense Oligonucleotides (ASO) Therapy Market witnessing a CAGR of 17.3% during the forecast period 2026-2032.

What is the Antisense Oligonucleotides (ASO) Therapy Market size in 2032?

Ans: The Antisense Oligonucleotides (ASO) Therapy Market size in 2032 will be US$ 14040 million.

Who are the main players in the Antisense Oligonucleotides (ASO) Therapy Market report?

Ans: The main players in the Antisense Oligonucleotides (ASO) Therapy Market are Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals

What are the Application segmentation covered in the Antisense Oligonucleotides (ASO) Therapy Market report?

Ans: The Applications covered in the Antisense Oligonucleotides (ASO) Therapy Market report are Neuromuscular Diseases, hATTR, Other

What are the Type segmentation covered in the Antisense Oligonucleotides (ASO) Therapy Market report?

Ans: The Types covered in the Antisense Oligonucleotides (ASO) Therapy Market report are Intrathecal Injection, Intravenous Injections, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Intrathecal Injection

1.2.3 Intravenous Injections

1.2.4 Other

1.3 Market by Application

1.3.1 Global Antisense Oligonucleotides (ASO) Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Perspective (2021–2032)

2.2 Global Antisense Oligonucleotides (ASO) Therapy Growth Trends by Region

2.2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Region (2021–2026)

2.2.3 Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Region (2027–2032)

2.3 Antisense Oligonucleotides (ASO) Therapy Market Dynamics

2.3.1 Antisense Oligonucleotides (ASO) Therapy Industry Trends

2.3.2 Antisense Oligonucleotides (ASO) Therapy Market Drivers

2.3.3 Antisense Oligonucleotides (ASO) Therapy Market Challenges

2.3.4 Antisense Oligonucleotides (ASO) Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antisense Oligonucleotides (ASO) Therapy Players by Revenue

3.1.1 Global Top Antisense Oligonucleotides (ASO) Therapy Players by Revenue (2021–2026)

3.1.2 Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top Antisense Oligonucleotides (ASO) Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Antisense Oligonucleotides (ASO) Therapy Revenue

3.4 Global Antisense Oligonucleotides (ASO) Therapy Market Concentration Ratio

3.4.1 Global Antisense Oligonucleotides (ASO) Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides (ASO) Therapy Revenue in 2025

3.5 Global Key Players of Antisense Oligonucleotides (ASO) Therapy Head Offices and Areas Served

3.6 Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Products and Applications

3.7 Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Antisense Oligonucleotides (ASO) Therapy Breakdown Data by Type

4.1 Global Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Type (2021–2026)

4.2 Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Type (2027–2032)

5 Antisense Oligonucleotides (ASO) Therapy Breakdown Data by Application

5.1 Global Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Application (2021–2026)

5.2 Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)

6.2 North America Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)

6.4 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)

7.2 Europe Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)

7.4 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)

8.2 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)

9.2 Latin America Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)

9.4 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)

10.2 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ionis Pharmaceuticals

11.1.1 Ionis Pharmaceuticals Company Details

11.1.2 Ionis Pharmaceuticals Business Overview

11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Introduction

11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

11.1.5 Ionis Pharmaceuticals Recent Development

11.2 Biogen

11.2.1 Biogen Company Details

11.2.2 Biogen Business Overview

11.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Introduction

11.2.4 Biogen Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

11.2.5 Biogen Recent Development

11.3 Sobi

11.3.1 Sobi Company Details

11.3.2 Sobi Business Overview

11.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Introduction

11.3.4 Sobi Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

11.3.5 Sobi Recent Development

11.4 Nippon Shinyaku

11.4.1 Nippon Shinyaku Company Details

11.4.2 Nippon Shinyaku Business Overview

11.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Introduction

11.4.4 Nippon Shinyaku Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

11.4.5 Nippon Shinyaku Recent Development

11.5 Jazz Pharmaceuticals

11.5.1 Jazz Pharmaceuticals Company Details

11.5.2 Jazz Pharmaceuticals Business Overview

11.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Introduction

11.5.4 Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

11.5.5 Jazz Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ionis Pharmaceuticals

Biogen

SOBI

Nippon Shinyaku

Jazz Pharmaceuticals

List of Tables

Table 1. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Intrathecal Injection

Table 3. Key Players of Intravenous Injections

Table 4. Key Players of Other

Table 5. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2021–2026

Table 8. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2021–2026)

Table 9. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2027–2032)

Table 11. Antisense Oligonucleotides (ASO) Therapy Market Trends

Table 12. Antisense Oligonucleotides (ASO) Therapy Market Drivers

Table 13. Antisense Oligonucleotides (ASO) Therapy Market Challenges

Table 14. Antisense Oligonucleotides (ASO) Therapy Market Restraints

Table 15. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Players (US$ Million), 2021–2026

Table 16. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Players (2021–2026)

Table 17. Global Top Antisense Oligonucleotides (ASO) Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antisense Oligonucleotides (ASO) Therapy Revenue, 2025

Table 18. Ranking of Global Top Antisense Oligonucleotides (ASO) Therapy Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Antisense Oligonucleotides (ASO) Therapy Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Headquarters and Area Served

Table 21. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Products and Applications

Table 22. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Type (US$ Million), 2021–2026

Table 25. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Type (2021–2026)

Table 26. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Type (2027–2032)

Table 28. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (US$ Million), 2021–2026

Table 29. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Application (2021–2026)

Table 30. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Application (2027–2032)

Table 32. North America Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026

Table 34. North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032

Table 47. Ionis Pharmaceuticals Company Details

Table 48. Ionis Pharmaceuticals Business Overview

Table 49. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product

Table 50. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026

Table 51. Ionis Pharmaceuticals Recent Development

Table 52. Biogen Company Details

Table 53. Biogen Business Overview

Table 54. Biogen Antisense Oligonucleotides (ASO) Therapy Product

Table 55. Biogen Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026

Table 56. Biogen Recent Development

Table 57. Sobi Company Details

Table 58. Sobi Business Overview

Table 59. Sobi Antisense Oligonucleotides (ASO) Therapy Product

Table 60. Sobi Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026

Table 61. Sobi Recent Development

Table 62. Nippon Shinyaku Company Details

Table 63. Nippon Shinyaku Business Overview

Table 64. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product

Table 65. Nippon Shinyaku Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026

Table 66. Nippon Shinyaku Recent Development

Table 67. Jazz Pharmaceuticals Company Details

Table 68. Jazz Pharmaceuticals Business Overview

Table 69. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product

Table 70. Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026

Table 71. Jazz Pharmaceuticals Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

Table 75. Authors List of This Report

List of Figures

Figure 1. Antisense Oligonucleotides (ASO) Therapy Picture

Figure 2. Global Antisense Oligonucleotides (ASO) Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Type: 2025 vs 2032

Figure 4. Intrathecal Injection Features

Figure 5. Intravenous Injections Features

Figure 6. Other Features

Figure 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Application: 2025 vs 2032

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. hATTR Case Studies

Figure 11. Other Case Studies

Figure 12. Antisense Oligonucleotides (ASO) Therapy Report Years Considered

Figure 13. Global Antisense Oligonucleotides (ASO) Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Antisense Oligonucleotides (ASO) Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region: 2025 vs 2032

Figure 16. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Players in 2025

Figure 17. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides (ASO) Therapy Revenue in 2025

Figure 19. North America Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)

Figure 21. United States Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)

Figure 25. Germany Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2021–2032)

Figure 33. China Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)

Figure 41. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)

Figure 45. Israel Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

Figure 49. Biogen Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

Figure 50. Sobi Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

Figure 51. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

Figure 52. Jazz Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global ASO based Drug Market Research Report 2024

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024

Global Antisense ODN Market Research Report 2024

Global Antisense Oligonucleotides Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024

Global Antisense Oligonucleotide Service Market Research Report 2025

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Drugs Market Research Report 2025

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

Global CNS Specific Antisense Oligonucleotides Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions